Payments for equipment utilization and the appropriateness of many emergency department scans will come under review by the Office of Inspector General under a fiscal year 2010 work plan.
Payments for equipment utilization and the appropriateness of many emergency department scans will come under review by the Office of Inspector General under a fiscal year 2010 work plan.
Every year the U.S. Department Health and Human Services Office of Inspector General (OIG) lists healthcare arrangements it believes cost too much or could violate federal fraud and abuse laws. Included in the 2010 OIG review is a look at the appropriateness of payments for x-rays performed in emergency departments.
OIG will also look at whether Medicare Part B payments reflect the actual expenses incurred by physicians and whether the utilization rate reflects current industry practices.
The Radiology Business Management Association recently published a study confirming actual equipment utilization is 54%, which is below the 75% called for in healthcare reform legislation from the House of Representatives.
Other projects include an ongoing examination of services and billing patterns in locations with a high density of independent diagnostic testing facilities.
"ACR members who render patient care in the areas listed in the work plan should not expect an immediate knock on their office door from the OIG," a press release from the American College of Radiology said. "However, it could happen, and to be prepared, radiologists and their staffs should properly document the medical necessity of and correct code for their services." Key elements of the work plan:
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.